Epigenetic changes in prostate cancer: implication for diagnosis and treatment. - Wikidata - awgldk - TriplyDB

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

http://www.wikidata.org/entity/Q34385658

about

Developmental exposure to estrogen alters differentiation and epigenetic programming in a human fetal prostate xenograft model Regulatory Variants and Disease: The E-Cadherin -160C/A SNP as an Example Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays Big Data Analytics for Prostate Radiotherapy The androgen receptor and stem cell pathways in prostate and bladder cancers (review)Dietary factors and epigenetic regulation for prostate cancer prevention Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy.Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.Hypermethylation of genes for diagnosis and risk stratification of prostate cancer Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction.Therapeutic Applications of Rose Hips from Different Rosa Species.Epigenetic Interactions between Alcohol and Cannabinergic Effects: Focus on Histone Modification and DNA Methylation.Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.Oxidative stress and DNA methylation in prostate cancer.Molecular genetics of prostate cancer: new prospects for old challenges Alterations of global histone H4K20 methylation during prostate carcinogenesis.The pathogenesis of prostate cancer: from molecular to metabolic alterations.Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cells Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer.Epigenetics of prostate cancer: beyond DNA methylation Metabolic imbalance and prostate cancer progression.Dietary manipulation of histone structure and function.Maturation of the developing human fetal prostate in a rodent xenograft model.Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.Epigenetics in breast and prostate cancer Aberrant DNA methylation and prostate cancer.Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.Epigenetics in prostate cancer.Colorimetric detection of both total genomic and loci-specific DNA methylation from limited DNA inputs.High-throughput detection of aberrant imprint methylation in the ovarian cancer by the bisulphite PCR-Luminex method AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.Molecular marks for epigenetic identification of developmental and cancer stem cells Genetic and epigenetic changes in human prostate cancer Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.Regulators of gene expression as biomarkers for prostate cancer

P2860

Q21131794-19C77C83-1B26-4AC4-9159-A202113C8DC6 Q21284519-DC79876B-69DD-4AAC-819C-3387F224573D Q21562455-957AF52F-4D13-4473-A6B1-C4D0E19CC188 Q26744485-9F2D2742-5BB4-4AD0-860C-BC2DDD329321 Q26853232-1D693AFB-F0B8-4172-993F-2BA522014E43 Q26991774-C45628EC-F847-44F6-A6B6-36C222C60334 Q28073470-E84D627B-3C3C-41E3-9A6D-83F8640AE846 Q28261485-94611FF9-44FF-4D22-A6FF-0AEE0B845217 Q28748604-D2F7AF68-DEEB-4991-BA7B-BE529B40AB87 Q30911744-2440804B-D277-46D2-97A6-3451CA0BD9E7 Q33373839-FCC61524-4D5B-4994-8698-BF2445C4B88B Q33410858-198F0C7E-7EB9-4ABD-9C64-1684F767BB95 Q33620784-8361C9F9-5B00-4B2F-8E29-9525442145D5 Q33838470-FC8C2006-B136-41F1-A8B9-F57B7733218F Q33914854-F3875BBA-912D-491D-99E7-349F531A9035 Q33949373-E2ECDE1B-EF91-442C-8FD2-76D4DF3D384C Q34021985-0449B253-C19E-4805-A9AB-60A4D4EE3F4F Q34127462-BDFD7ABA-96D3-42CE-A12D-9CC78A3BB46D Q34194181-BD8B839B-AC0B-44CC-A206-0E771F7953CF Q34201846-3480FFAE-2B44-49D1-A2F3-179CB1EC9239 Q34405780-A91AB005-0624-476E-A2A6-D0AD9A068DC4 Q34496888-66BF5F77-293E-4A0E-9A76-700BFFBFD411 Q34505232-6EC39838-DCDA-4635-86E6-9D75DC2837A5 Q34794028-DAD88E5D-6533-4917-A5E3-EB2CBD9DFBCA Q34898711-61A8B9FD-1618-475B-A6CB-8D556DC19D3D Q34987740-BBE92C9B-9FDE-471C-AF79-94F41A12FA4B Q35070323-2AC35D50-04C0-48D7-8E1D-E02D67BF654F Q35178504-D0E208CC-FB21-4DFD-85EA-D91AF76E40E0 Q35190483-FF072F84-E2E4-4C2B-8685-FAA61D408F4F Q35560819-57CF1AB1-57C9-45FE-ABF3-2194EE1DFF77 Q35572461-466FC056-CDA2-4D2A-BF35-8FA45DA504E4 Q35596729-62A7857E-968C-4F05-B746-574A91FAC0FE Q35608952-A293D303-7DF8-4DF9-A4B5-74A1F89093FC Q35838583-804820F6-8AD3-457F-8927-7FD043A2A181 Q35927844-9947781C-5BEA-499D-8C6C-2A45867A91E0 Q35989658-5F1F5099-E241-4C3A-8F1D-848AA5D1E513 Q36001860-A875DC11-423B-4CC8-9AAD-26D75A946D84 Q36022274-A4490327-430F-41A2-93BD-3D08E4A5F41F Q36065002-6867C28D-7589-4FDD-A7C5-3AA623ACCFC9 Q36439912-053C19B1-DBBE-4CF0-854A-99705A0C72D0

P2860

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

http://www.wikidata.org/entity/Q34385658

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@ast

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@en

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@nl

type

label

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@ast

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@en

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@nl

prefLabel

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@ast

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@en

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@nl

P1433

Q34385658-ED425CBC-193E-45BA-BFED-3CBE8B8150D3

P1476

Q34385658-17B2A6AD-6574-4AB5-A4C6-1F7C065AF14A

P2093

Q34385658-A0CAD3D3-75FB-4CBF-A1AE-2A9797763E02

Q34385658-AB7E113A-584A-4208-A1CD-F6518529785D

Q34385658-D043ECB9-CB58-4783-93F4-83503B95074F

P2860

Q34385658-0143F190-0C21-4E50-8437-325576F206BC

Q34385658-02D0C846-7731-4CE1-B73E-62A3692C3B18

Q34385658-05483125-81CE-48BD-872A-38162B8E7CA8

Q34385658-05534AA2-626D-4F70-90F5-71A6AD6E65FA

Q34385658-0CE2B513-C938-4301-B329-22661A491C5A

Q34385658-0FE8DB15-32C8-4BD2-8A87-572F3BE54B99

Q34385658-1405D01E-313F-4455-AFB7-3A87E0C7F915

Q34385658-150C54A8-8144-4D9C-A2CB-7976543BF2DE

Q34385658-162B788F-5A20-444F-A047-635F203A773C

Q34385658-17EDD10B-E32F-4D5E-8F61-BB5C4B234028

P304

Q34385658-20D560BD-7B20-4FA3-947A-46A41899F7F1

P31

Q34385658-CABCCC14-ABCF-4F89-85C5-A2994898B4B6

P356

Q34385658-751CB2BB-0809-451E-8EA2-7E98CED32298

P407

Q34385658-13341713-5640-4F2F-9F2D-89C89A3DD7F2

P433

Q34385658-F8CBDA9E-3C97-4437-840E-956F2725B057

P478

Q34385658-3F64420A-6E4B-49AC-98CC-2DD24B3A6CA1

P577

Q34385658-62E558D0-623A-44A7-A7DA-E4D07EC7F587

P5875

Q34385658-8D73B83C-8AE5-424B-9AEF-8239EBA79001

P698

Q34385658-019985F6-26C3-4954-9ACD-3EC9B8444698

P356

P1433

Journal of the National Cancer Institute

P1476

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

@en

P2093

Long-Cheng Li

http://www.w3.org/2001/XMLSchema#string

Peter R Carroll

http://www.w3.org/2001/XMLSchema#string

Rajvir Dahiya

http://www.w3.org/2001/XMLSchema#string

P2860

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors

Translating the Histone Code

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription

High sensitivity mapping of methylated cytosines

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase

CpG islands in vertebrate genomes

CpG-rich islands and the function of DNA methylation

P304

103-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJI010

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8074757

http://www.w3.org/2001/XMLSchema#string

P698

15657340

http://www.w3.org/2001/XMLSchema#string